Effect of Adjuvants on Antibody Titer of Synthetic Recombinant Light Chain of Botulinum Neurotoxin Type B and its Diagnostic Potential for Botulism |
Jain, Swati
(Biotechnology Division, Defence Research and Development Establishment)
Ponmariappan, S. (Biotechnology Division, Defence Research and Development Establishment) Kumar, Om (Biotechnology Division, Defence Research and Development Establishment) Singh, Lokendra (Biotechnology Division, Defence Research and Development Establishment) |
1 | Agarwal, A. K., A. Goel, A. Kohli, A. Rohtagi, and R. Kumar. 2004. Food-borne botulism. J. Assoc. Physicians India 52: 677-678. |
2 | Akdeniz, H., T. Buzgan, M. Tekin, H. Karsen, and M. K. Karahocagil. 2007. An outbreak of botulism in a family in Eastern Anatolia associated with eating suzme yoghurt buried under soil. Scand. J. Infect. Dis. 39: 108-114. DOI ScienceOn |
3 | Gill, D. M. 1982. Bacterial toxins: A table of lethal amounts. Microbiol. Rev. 46: 86-94. |
4 | Bomford, R. 1980. The comparative selectivity of adjuvants for humoral and cell-mediated immunity. I. Effect on the antibody response to bovine serum albumin and sheep red blood cells of Freund's incomplete and complete adjuvants, alhydrogel, Corynebacterium parvum, Bordetella pertussis, muramyl dipeptide and saponin. Clin. Exp. Immunol. 39: 426-434. |
5 | Cai, S., B. R. Singh, and S. Sharma. 2007. Botulism diagnostics: From clinical symptoms to in vitro assays. Crit. Rev. Microbiol. 33: 109-125. DOI ScienceOn |
6 | Dillon, P. J. and C. A. Rosen. 1990. A rapid method for the construction of synthetic genes using the polymerase chain reaction. Biotechniques 9: 298, 300. |
7 | Sobel, J., M. Malavet, and S. John. 2007. Outbreak of clinically mild botulism type E illness from home-salted fish in patients presenting with predominantly gastrointestinal symptoms. Clin. Infect. Dis. 45: e14-e16. DOI |
8 | Arnon, S. S., R. Schechter, T. V. Inglesby, D. A. Henderson, J. G. Bartlett, M. S. Ascher, et al. 2001. Botulinum toxin as a biological weapon: Medical and public health management. J. Am. Med. Assoc. 285: 1059-1070. DOI ScienceOn |
9 | Sheth, A. N., P. Wiersma, D. Atrubin, V. Dubey, D. Zink, G. Skinner, et al. 2008. International outbreak of severe botulism with prolonged toxemia caused by commercial carrot juice. Clin. Infect. Dis. 47: 1245-1251. DOI ScienceOn |
10 | Singh, B. R. 2000. Intimate details of the most poisonous poison. Nat. Struct. Biol. 7: 617-619. DOI ScienceOn |
11 | Szilagyi, M., V. R. Rivera, D. Neal, G. A. Merrill, and M. A. Poli. 2000. Development of sensitive colorimetric capture ELISAs for Clostridium botulinum neurotoxin serotypes A and B. Toxicon 38: 381-389. DOI ScienceOn |
12 | Vaidyanathan, V. V., K. Yoshino, M. Jahnz, C. Dorries, S. Bade, S. Nauenburg, H. Niemann, and T. Binz. 1999. Proteolysis of SNAP-25 isoforms by botulinum neurotoxin types A, C, and E: Domains and amino acid residues controlling the formation of enzyme-substrate complexes and cleavage. J. Neurochem. 72: 327-337. DOI |
13 | Vugia, D. J., S. R. Mase, B. Cole, J. Stiles, J. Rosenberg, L. Velasquez, A. Radner, and G. Inami. 2009. Botulism from drinking pruno. Emerg. Infect. Dis. 15: 69-71. DOI |
14 | Schmidt, J. J. and K. A. Bostian. 1995. Proteolysis of synthetic peptides by type A botulinum neurotoxin. J. Protein Chem. 14: 703-708. DOI ScienceOn |
15 | Schiavo, G., F. Benfenati, B. Poulain, O. Rossetto, P. Polverino de Laureto, B. R. DasGupta, and C. Montecucco. 1992. Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin. Nature 359: 832-835. DOI ScienceOn |
16 | Schiavo, G., O. Rossetto, S. Catsicas, P. Polverino de Laureto, B. R. DasGupta, F. Benfenati, and C. Montecucco. 1993. Identification of the nerve terminal targets of botulinum neurotoxin serotypes A, D, and E. J. Biol. Chem. 268: 23784-23787. |
17 | Schiavo, G., C. C. Shone, O. Rossetto, F. C. Alexander, and C. Montecucco. 1993. Botulinum neurotoxin serotype F is a zinc endopeptidase specific for VAMP/synaptobrevin. J. Biol. Chem. 268: 11516-11519. |
18 | Montecucco, C. and G. Schiavo. 1995. Structure and function of tetanus and botulinum neurotoxins. Q. Rev. Biophys. 28: 423-472. DOI |
19 | Sharma, S. K., B. S. Eblen, R. L. Bull, D. H. Burr, and R. C. Whiting. 2005. Evaluation of lateral-flow Clostridium botulinum neurotoxin detection kits for food analysis. Appl. Environ. Microbiol. 71: 3935-3941. DOI ScienceOn |
20 | Montecucco, C. and G. Schiavo. 1994. Mechanism of action of tetanus and botulinum neurotoxins. Molec. Microbiol. 13: 1-8. DOI ScienceOn |
21 | Oguma, K., Y. Fujinaga, and K. Inoue. 1995. Structure and function of Clostridium botulinum toxins. Microbiol. Immunol. 39: 161-168. DOI |
22 | Gilsdorf, J., N. Gul, and L. A. Smith. 2006. Expression, purification, and characterization of Clostridium botulinum type B light chain. Protein Expr. Purif. 46: 256-267. DOI ScienceOn |
23 | Rivera, V. R., F. J. Gamez, W. K. Keener, J. A. White, and M. A. Poli. 2006. Rapid detection of Clostridium botulinum toxins A, B, E, and F in clinical samples, selected food matrices, and buffer using paramagnetic bead-based electrochemiluminescence detection. Anal. Biochem. 353: 248-256. DOI ScienceOn |
24 | Rossetto, O., F. Deloye, B. Poulain, R. Pellizzari, G. Schiavo, and C. Montecucco. 1995. The metallo-proteinase activity of tetanus and botulism neurotoxins. J. Physiol. Paris 89: 43-50. DOI ScienceOn |
25 | Sakaguchi, G. 1982. Clostridium botulinum toxins. Pharmacol. Ther. 19: 165-194. DOI ScienceOn |
26 | Harandi, A. M., D. Medaglini, and R. J. Shattock. 2010. Vaccine adjuvants: A priority for vaccine research. Vaccine 28: 2363-2366. DOI ScienceOn |
27 | King, L. A., T. Niskanen, M. Junnikkala, E. Moilanen, M. Lindstrom, H. Korkeala, et al. 2009. Botulism and hot-smoked whitefish: A family cluster of type E botulism in France, September 2009. Euro. Surveill. 14(45): pii=19394. |
28 | Barash, J. R., T. W. Tang, and S. S. Arnon. 2005. First case of infant botulism caused by Clostridium baratii type F in California. J. Clin. Microbiol. 43: 4280-4282. DOI ScienceOn |
29 | Binz, T., J. Blasi, S. Yamasaki, A. Baumeister, E. Link, T. C. Sudhof, R. Jahn, and H. Niemann. 1994. Proteolysis of SNAP- 25 by types E and A botulinal neurotoxins. J. Biol. Chem. 269: 1617-1620. |
30 | Blasi, J., E. R. Chapman, E. Link, T. Binz, S. Yamasaki, P. De Camilli, T. C. Sudhof, H. Niemann, and R. Jahn. 1993. Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25. Nature 365: 160-163. DOI ScienceOn |
31 | Lacy, D. B. and R. C. Stevens. 1999. Sequence homology and structural analysis of the clostridial neurotoxins. J. Mol. Biol. 291: 1091-1104. DOI ScienceOn |
32 | Doellgast, G. J., M. X. Triscott, G. A. Beard, J. D. Bottoms, T. Cheng, B. H. Roh, M. G. Roman, P. A. Hall, and J. E. Brown. 1993. Sensitive enzyme-linked immunosorbent assay for detection of Clostridium botulinum neurotoxins A, B, and E using signal amplification via enzyme-linked coagulation assay. J. Clin. Microbiol. 31: 2402-2409. |
33 | Blasi, J., E. R. Chapman, S. Yamasaki, T. Binz, H. Niemann, and R. Jahn. 1993. Botulinum neurotoxin C1 blocks neurotransmitter release by means of cleaving HPC-1/syntaxin. EMBO J. 12: 4821-4828. |
34 | Foran, P., G. W. Lawrence, C. C. Shone, K. A. Foster, and J. O. Dolly. 1996. Botulinum neurotoxin C1 cleaves both syntaxin and SNAP-25 in intact and permeabilized chromaffin cells: Correlation with its blockade of catecholamine release. Biochemistry 35: 2630-2636. DOI ScienceOn |
35 | Franz, D. R., P. B. Jahrling, A. M. Friedlander, D. J. McClain, D. L. Hoover, W. R. Bryne, J. A. Pavlin, G. W. Christopher, and E. M. Eitzen Jr. 1997. Clinical recognition and management of patients exposed to biological warfare agents. J. Am. Med. Assoc. 278: 399-411. DOI ScienceOn |
36 | Frean, J., L. Arntzen, J. van den Heever, and O. Perovic. 2004. Fatal type A botulism in South Africa, 2002. Trans. R. Soc. Trop. Med. Hyg. 98: 290-295. DOI |